Country Focus: Healthcare, Regulatory and Reimbursement Landscape - Norway

Country Focus: Healthcare, Regulatory and Reimbursement Landscape - Norway


  • Products Id :- GDHC0044CHR
  • |
  • Pages: 127
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Norway

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Norway". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Norway. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Norway. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Norway is a mature healthcare market, with a strong focus on healthcare spending. It spends approximately 10.5% of its GDP on healthcare. The value of the Norwegian pharmaceutical market increased from USD 2.18 billion in 2010 to USD 2.37 billion in 2017, at a Compound Annual Growth Rate (CAGR) of 1.2%. The market is forecast to grow to USD 2.53 billion in 2022. The medical device market increased from USD 1.31 billion in 2010 to USD 1.71 billion in 2017. The market is expected to grow at a CAGR of 4.9% from USD 1.79 billion in 2018 to USD 2.17 billion in 2022. The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of pharmaceutical market. However, generic substitution and parallel imports pose as a barrier for the pharmaceutical companies.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Norway, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Merck, Leo Pharma, Bayer and Vistin Pharma) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Philips Healthcare, Roche Diagnostics, Essilor and Photocure)

- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Norway

- Porter's five forces analysis for pharmaceutical and medical devices market of Norway

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Norwegian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the Norwegian healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the Norwegian healthcare market



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary

Overview of Pharmaceutical Market

Overview of Medical Device Market

Deals Analysis

Porter's Five Forces Model

Market Access

Country Healthcare Landscape

Opportunities and Challenges

Appendix

List of Figures

Figure 1: Pharmaceutical Market, Norway, Revenue (USD bn), 2010-2017 8

Figure 2: Medical Device Market, Norway, Revenue (USD bn), 2010-2017 8

Figure 3: Country Profile, Norway, 2017 14

Figure 4: Pharmaceutical Market, Norway, Revenue (USD bn), 2010-2017 16

Figure 5: Pharmaceutical Market, Norway, Revenue Forecast (USD bn), 2018-2022 16

Figure 6: Pharmaceutical Exports (USD bn), Norway, 2010-2016 17

Figure 7: Top Export Partners, Norway, 2016 17

Figure 8: Pharmaceutical Imports (USD bn), Norway, 2010-2016 18

Figure 9: Top Import Partners, Norway, 2016 18

Figure 10: Pharmaceutical Value Chain, Norway, 2017 19

Figure 11: Pharmaceutical Market, Norway, Pharmaceutical Sales by Therapeutic Area(USD m), 2017 21

Figure 12: Pharmaceutical Market, Norway, Major Players 23

Figure 13: Medical Device Market, Norway, Revenue (USD bn), 2010-2017 39

Figure 14: Medical Device Market, Norway, Revenue Forecast (USD bn), 2018-2022 39

Figure 15: Medical Device Market, Norway, Revenue by Segment (USD m), 2017 40

Figure 16: IVD Devices Market, Norway, Revenue (USD m), 2010-2017 41

Figure 17: IVD Devices Market, Norway, Market Share of Major Players (%), 2017 41

Figure 18: Ophthalmic Devices Market, Norway, Revenue (USD m), 2010-2017 42

Figure 19: Ophthalmic Devices Market, Norway, Market Share of Major Players (%), 2015 42

Figure 20: Orthopedic Devices Market, Norway, Revenue (USD m), 2010-2017 43

Figure 21: Orthopedic Devices Market, Norway, Market Share of Major Players (%), 2016 43

Figure 22: Healthcare IT Market, Norway, Revenue (USD m), 2010-2017 44

Figure 23: Healthcare IT Market, Norway, Market Share of Major Players (%), 2016 44

Figure 24: Cardiovascular Devices Market, Norway, Revenue (USD m), 2010-2017 45

Figure 25: Cardiovascular Devices Market, Norway, Market Share of Major Companies (%), 2017 45

Figure 26: Diagnostic Market, Norway, Revenue (USD m), 2010-2017 46

Figure 27: Diagnostic Market, Norway, Revenue (USD m), 2018-2022 46

Figure 28: Medical Device Market, Norway, Revenue (USD bn) of Major Companies, 2016 48

Figure 29: Deal Value and Deal Count, Pharmaceutical Market, Norway, 2017-2018 68

Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Norway, 2017-2018 68

Figure 31: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Norway, 2017-2018 68

Figure 32: Pharmaceutical Market, Norway, Top Five Therapy Areas by Deal Value (USD m), 2017-2018 69

Figure 33: Pharmaceutical Market, Norway, Top Five Therapy Areas by Deal Number, 2017-2018 69

Figure 34: Pharmaceutical Market, Norway, M&A Deals by Therapy Area, 2017-2018 69

Figure 35: Pharmaceutical Market, Norway, Venture Financing Deals by Therapy Area, 2017-2018 69

Figure 36: Medical Device Market Deals by Deal Value (USD m), Norway, 2017-2018 70

Figure 37: Medical Device Market Deals by Deal Count, Norway, 2017-2018 70

Figure 38: Medical Device Market Deals Share by Deal Count, Norway, 2017-2018 70

Figure 39: Medical Device Market Deals Share (by deal value), Norway, 2017-2018 70

Figure 40: Medical Device, Norway, Top Therapy Area by Deal Value, 2017-2018 71

Figure 41: Medical Devices, Norway, Top Therapy Area by Deal Number, 2017-2018 71

Figure 42: Medical Devices, Norway, M&A Deals by Therapy Area, 2017-2018 71

Figure 43: Medical Devices, Norway, Venture Financing Deals by Therapy Area, 2017-2018 71

Figure 44: Medical Devices, Norway, Private Equity Deals by Therapy Area, 2017-2018 71

Figure 45: Organization of the Health System, Norway, 2016 76

Figure 46: Decision Making Process, Norway, 2015 77

Figure 47: Out-of-Pocket Expenditure (% of total expenditure on health), Norway, 2010-2016 81

Figure 48: Annual Rate of Change (%), Health Price Index, Norway, 2010-2017 81

Figure 49: Norway Medicines Agency, Organization Chart, 2017 83

Figure 50: National Procedure, Norway, 2017 85

Figure 51: Centralized Procedure, Norway, 2017 86

Figure 52: Decentralized Procedure, Norway, 2017 87

Figure 53: Medical Device Market Deals Share (by deal value), Norway, 2017-2018 70

Figure 54: Medical Device, Norway, Top Therapy Area by Deal Value, 2017-2018 71

Figure 55: Mutual Recognition Procedure, Norway, 2017 88

Figure 56: Conformity Assessment of Class I Medical Devices, EU, 2017 90

Figure 57: Conformity Assessment of Class IIa Medical Devices, EU, 2017 91

Figure 58: Conformity Assessment of Class IIb Medical Devices, EU, 2017 92

Figure 59: Conformity Assessment of Class III Medical Devices, EU, 2017 93

Figure 60: European Patent Approval Process, EU, 2017 96

Figure 61: Number of Hospitals, Norway,2010-2017 104

Figure 62: Diagnostic Equipment (per million population), Norway,2010-2017 104

Figure 63: Hospital Beds (per 1,000 population), Norway, 2010-2017 105

Figure 64: Curative Care Hospital Beds (per 1,000 population), Norway, 2010-2017 105

Figure 65: Psychiatric Hospital Beds (per 1,000 population), Norway, 2010-2017 105

Figure 66: Life Expectancy (in years), Norway, 2010-2017 106

Figure 67: Immunization Rate (%), Norway, 2010-2017 106

Figure 68: PM2.5 (?g per m3), Norway, 2010-2017 107

Figure 69: CO2 Emissions (metric tons per capita), Norway, 2010-2017 107

Figure 70: Physicians (per 1,000 population), Norway, 2010-2017 108

Figure 71: Nurses (per 1,000 population), Norway, 2010-2017 108

Figure 72: Dentists, (per 1,000 population), Norway, 2010-2017 108

Figure 73: Pharmacists, (per 1,000 population), Norway, 2010-2017 108

Figure 74: Major Causes of Mortality (Number of Deaths, '000), Norway, 2015 109

Figure 75: Major Causes of Male Mortality (Number of Deaths, '000), Norway, 2015 109

Figure 76: Major Causes of Female Mortality (Number of Deaths, '000), Norway, 2015 109

Figure 77: Disability-Adjusted Life Years by Major Disease ('000), Norway, 2015 109

Figure 78: Healthcare Expenditure as Percentage of GDP (%), Norway, 2010-2017 110

Figure 79: Public-Private Share (%), Norway, 2010-2017 110

Figure 80: Major Components of Healthcare Expenditure(%), Norway, 2016 111

Figure 81: Spending in Pharmaceutical and Healthcare R&D (USD m), Norway, 2010-2015 111

Figure 82: Opportunities & Challenges, Norway 115

List of Tables

Table 1: OTC Market, Norway, Top Product Sales (USD m), 2017 20

Table 2: Pharmaceutical Market, Norway, Pharmaceutical Sales by Therapeutic Area (USD m), 2017 21

Table 3: IVD Devices Market, Norway, Revenue (USD m) and Market Share (%) of Major Companies, 2017 41

Table 4: Ophthalmic Devices Market, Norway, Revenue (USD m) and Market Share (%) of Major Companies, 2015 42

Table 5: Orthopedic Devices Market, Norway, Revenue (USD m) and Market Share (%) of Major Companies, 2016 43

Table 6: Healthcare IT Market, Norway, Revenue (USD m) and Market Share (%) of Major Companies, 2016 44

Table 7: Cardiovascular Devices Market, Norway, Revenue (USD m) and Market Share (%) of Major Companies, 2017 45

Table 8: Reimbursement Categories and Rates, Norway, 2015 78

Table 9: National Insurance Contribution Rates, Norway, 2016 79

Table 10: Pricing Procedures, Norway, 2015 82

Table 11: Market Authorization Fees, Norway, 2018 84

Table 12: Types of Import Authorizations for Clinical Studies, Norway, 2017 94

Table 13: Patent Fees, Norway, 2017 95

Table 14: Trademark Fees, Norway, 2017 97

Table 15: Clinical Trial Regulation, Norway, 2017 98

Table 16: Advertising Regulations, Norway, 2017 99

Table 17: Labeling and Packaging Regulations, Norway, 2017 101

Table 18: Nordic Package 101

Table 19: Trade Fairs, Norway, 2018-2019 113

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Norway, Pharmaceutical Market, Medical Device Market, Drivers and Barriers, Major Players, Deals,Porter's Five Forces Regulatory Landscape, Reimbursement landscape, Country Healthcare Landscape, Opportunities and Challenges

select a license
Single User License
USD 1995 INR 143321
Site License
USD 3990 INR 286642
Corporate User License
USD 5985 INR 429962

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com